Related Experiment Video
Updated: Jan 20, 2026

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
Published on: June 27, 2011
Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated
Kazuma Yamakawa1, Jerrold H Levy2, Toshiaki Iba3
1Division of Trauma and Surgical Critical Care, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi, Osaka, 558-8558, Japan. k.yamakawa0911@gmail.com.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
07:45A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:01A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice
Solubility Equilibria
The...
06:26Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)
07:42A Data-Driven Approach to Quantifying Immune States in Sepsis

